HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paolo Martelletti Selected Research

tonabersat

9/2012Emerging treatment for chronic migraine and refractory chronic migraine.
10/2009Future drugs for migraine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paolo Martelletti Research Topics

Disease

113Migraine Disorders (Migraine)
06/2022 - 05/2002
43Headache (Headaches)
06/2022 - 04/2005
18Pain (Aches)
05/2021 - 01/2004
11COVID-19
04/2022 - 01/2020
10Cluster Headache (Cluster Headaches)
05/2020 - 11/2011
7Epilepsy (Aura)
05/2020 - 05/2002
7Headache Disorders (Headache Syndromes)
05/2019 - 12/2006
6Secondary Headache Disorders
01/2018 - 04/2006
5Prescription Drug Overuse
06/2022 - 12/2011
4Ischemic Stroke
01/2020 - 02/2007
3Inflammation (Inflammations)
04/2022 - 02/2007
3Pneumonia (Pneumonitis)
04/2022 - 11/2020
3Mood Disorders (Mood Disorder)
12/2021 - 08/2009
3Infections
01/2021 - 01/2020
3Migraine with Aura (Familial Hemiplegic Migraine)
10/2017 - 05/2002
2Chronic Obstructive Pulmonary Disease (COPD)
11/2021 - 06/2021
2Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 11/2020
2Substance Withdrawal Syndrome (Withdrawal Symptoms)
04/2021 - 08/2015
2Drug-Related Side Effects and Adverse Reactions
09/2020 - 03/2019
2Post-Traumatic Headache
05/2020 - 01/2004
2Neurogenic Inflammation
05/2020 - 08/2019
2Acute Pain
01/2015 - 01/2015
2Tension-Type Headache (Tension Headache)
10/2014 - 02/2007
2Mental Disorders (Mental Disorder)
02/2014 - 08/2009
1Thrombosis (Thrombus)
04/2022
1Neuroinflammatory Diseases
12/2021
1Stroke (Strokes)
12/2021
1Venous Thromboembolism
12/2021
1Depressive Disorder (Melancholia)
07/2021
1Hypertension (High Blood Pressure)
07/2021
1Anxiety Disorders (Anxiety Disorder)
07/2021
1Cough
06/2021

Drug/Important Bio-Agent (IBA)

31Pharmaceutical PreparationsIBA
05/2022 - 02/2007
25Tryptamines (Triptans)IBA
05/2021 - 09/2008
24Type A Botulinum Toxins (Botox)FDA Link
12/2021 - 01/2004
21Calcitonin Gene-Related PeptideIBA
06/2022 - 10/2009
15Monoclonal AntibodiesIBA
06/2022 - 02/2015
10Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
05/2021 - 06/2012
6erenumabIBA
06/2022 - 01/2017
6lasmiditanIBA
05/2021 - 09/2012
6Sumatriptan (Imigran)FDA LinkGeneric
10/2014 - 09/2008
5galcanezumabIBA
06/2022 - 02/2015
5fremanezumabIBA
06/2022 - 12/2018
5Biomarkers (Surrogate Marker)IBA
04/2022 - 09/2009
5N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2021 - 10/2009
5Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
05/2020 - 06/2012
5Serotonin (5 Hydroxytryptamine)IBA
02/2020 - 02/2014
5Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2020 - 01/2004
5salicylhydroxamic acid (SHAM)IBA
01/2019 - 01/2018
5Pain-FreeIBA
11/2018 - 06/2011
4eptinezumabIBA
06/2022 - 02/2015
4Topiramate (Topamax)FDA LinkGeneric
08/2019 - 07/2010
4preemptIBA
03/2019 - 12/2011
4Valproic Acid (Depakote)FDA LinkGeneric
08/2018 - 07/2010
4KynurenineIBA
12/2015 - 01/2015
4almotriptan (Axert)FDA Link
05/2013 - 06/2011
3TroponinIBA
04/2022 - 11/2020
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2022 - 02/2007
3VaccinesIBA
03/2022 - 01/2020
3Hormones (Hormone)IBA
12/2021 - 05/2014
35-HT1F Serotonin ReceptorIBA
05/2021 - 02/2015
3ubrogepantIBA
05/2021 - 01/2019
3Analgesics (Analgesic Drugs)IBA
04/2021 - 01/2015
3Peptides (Polypeptides)IBA
04/2021 - 10/2009
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 01/2004
3Contraceptive Agents (Contraceptives)IBA
01/2020 - 10/2017
3Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA
01/2018 - 09/2012
3Glutamic Acid (Glutamate)FDA Link
06/2015 - 10/2009
3Anticonvulsants (Antiepileptic Drugs)IBA
08/2014 - 07/2010
3frovatriptan (Allegro)FDA Link
07/2012 - 06/2011
3telcagepantIBA
06/2012 - 09/2008
3olcegepantIBA
06/2012 - 09/2008
2fibrin fragment D (D-dimer)IBA
04/2022 - 11/2020
2Estrogens (Estrogen)FDA Link
12/2021 - 08/2018
2Natriuretic PeptidesIBA
11/2021 - 11/2020
2rimegepant sulfateIBA
05/2021 - 01/2019
2Calcitonin (Calcitonin, Eel)FDA LinkGeneric
04/2021 - 08/2019
2Glutamate Receptors (Glutamate Receptor)IBA
01/2021 - 02/2015
2Neurotransmitter Agents (Neurotransmitter)IBA
10/2020 - 08/2019
2Dehydroepiandrosterone (DHEA)IBA
05/2019 - 04/2006
2Botulinum Toxins (Botulinum Toxin)IBA
03/2019 - 09/2017
2Serotonin ReceptorsIBA
01/2018 - 02/2015
2tonabersatIBA
09/2012 - 10/2009
21- (N(2)- (3,4- dibromo- N- ((4- (3,4- dihydro- 2(1H)- oxoquinazolin- 3- yl)- 1- piperidinyl)carbonyl)tyrosyl)lysyl)- 4- (4- pyridinyl)piperazineIBA
10/2009 - 09/2008
1BNT162 VaccineIBA
03/2022
1Messenger RNA (mRNA)IBA
03/2022
1Gonadal Steroid Hormones (Sex Hormones)IBA
12/2021
1Hemoglobins (Hemoglobin)IBA
11/2021
1CI 22IBA
07/2021

Therapy/Procedure

41Therapeutics
06/2022 - 01/2004
10Drug Therapy (Chemotherapy)
01/2021 - 01/2004
6Vagus Nerve Stimulation
01/2019 - 10/2013
3Polypharmacy
06/2021 - 09/2020
3Contraindications
05/2021 - 01/2019
3Contraception (Birth Control)
10/2018 - 10/2017
2Injections
05/2020 - 12/2006
2Precision Medicine
05/2019 - 01/2018
2Aftercare (After-Treatment)
10/2018 - 09/2015
2Transcutaneous Electric Nerve Stimulation (TENS)
10/2013 - 01/2004
1Transjugular Intrahepatic Portasystemic Shunt
06/2022